<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 187274 12312018 20F.xfr; Date: 2019%2D03%2D29T00:20:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80150000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2018-03-16/ifrs-full" xmlns:IFRX="http://inflarx.com/20181231">
    <link:schemaRef xlink:href="ifrx-20181231.xsd" xlink:type="simple" />
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_PersonnelExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:PersonnelExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_PersonnelExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:PersonnelExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_PrepaidExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaidExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_PrepaidExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">IFRX:PrepaidExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_WithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:WithinOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_MoreThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:MoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_OtherExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:OtherExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_ThirdPartyServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ThirdPartyServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_PersonnelExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:PersonnelExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_LegalAndConsultingFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:LegalAndConsultingFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_WagesAndSalariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:WagesAndSalariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_SocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:SocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_ifrs-full_CapitalReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_ExecutiveManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:ExecutiveManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_NonExecutiveBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">IFRX:NonExecutiveBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OnePercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:OnePercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OnePercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:OnePercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_FivePercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:FivePercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_FivePercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:FivePercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TenPercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:TenPercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TenPercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:TenPercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_InflarxNVMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxNVMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OnePercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:OnePercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OnePercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:OnePercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_FivePercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:FivePercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_FivePercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:FivePercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TenPercentIncreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:TenPercentIncreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TenPercentDecreaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ForeignExchangeAxis">IFRX:TenPercentDecreaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_ifrs-full_SharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_OtherComponentsOfEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">IFRX:OtherComponentsOfEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_ManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_ClinicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:ClinicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_StockbasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:StockbasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_StockbasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:StockbasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_StockbasedCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpenseByNatureAxis">IFRX:StockbasedCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ForeignExchangesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_InterestIncomeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:InterestIncomeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_FinanceIncomeCostOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:FinanceIncomeCostOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ForeignExchangesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_FinanceIncomeCostOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:FinanceIncomeCostOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_ForeignExchangesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:ForeignExchangesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_FinanceIncomeCostOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:IncomeByNatureAxis">IFRX:FinanceIncomeCostOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_InflarxNVMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxNVMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_InflarxGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_InflarxGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_MarketRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">ifrs-full:MarketRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_ifrs-full_CreditRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_LiquidityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">IFRX:LiquidityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OneToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:OneToFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MinimumLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:MinimumLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ContingentRentalsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:ContingentRentalsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_WithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:WithinOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_OneToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:OneToFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_MoreThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">IFRX:MoreThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_MinimumLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:MinimumLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ContingentRentalsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:ContingentRentalsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InflarxNVMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxNVMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InflarxPharmaceuticalsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxPharmaceuticalsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_InflarxNVMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxNVMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_InflarxPharmaceuticalsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ParentAxis">IFRX:InflarxPharmaceuticalsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Q1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Q2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Q3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Q31Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q31Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Q4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Q1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Q2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Q3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Q31Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q31Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Q4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">IFRX:Q4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SubleaseIncomeMember9747379">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:SubleaseIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_SubleaseIncomeMember9747426">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="IFRX:ExpensesByNatureAxis">IFRX:SubleaseIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001708688</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="EUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EURPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:EUR</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Rate">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>IFRX:Percent</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EURPerUSD">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:EUR</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2018-01-01to2018-12-31">InflaRx N.V.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2018-01-01to2018-12-31">0001708688</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2018-01-01to2018-12-31">20-F/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2018-01-01to2018-12-31">2018-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2018-01-01to2018-12-31">true</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2018-01-01to2018-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2018-01-01to2018-12-31">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2018-01-01to2018-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2018-01-01to2018-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2018-01-01to2018-12-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2018-01-01to2018-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2018-01-01to2018-12-31">2018</dei:DocumentFiscalYearFocus>
    <dei:EntityEmergingGrowthCompany contextRef="From2018-01-01to2018-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2018-01-01to2018-12-31">false</dei:EntityShellCompany>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">25028000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">14415000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">661000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">235000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="-3">15909000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="-3">8856000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">8037000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">4681000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">421000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">643000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">5278000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">132000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_ThirdPartyServicesMember" unitRef="EUR" decimals="-3">3757000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">1293000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">95000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ManufacturingMember" unitRef="EUR" decimals="-3">4829000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_ManufacturingMember" unitRef="EUR" decimals="-3">5559000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_ManufacturingMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_ClinicalMember" unitRef="EUR" decimals="-3">11080000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_ClinicalMember" unitRef="EUR" decimals="-3">3297000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_ClinicalMember" unitRef="EUR" xsi:nil="true" />
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">5256000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">3071000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">302000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">12787000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">5138000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">1619000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">712000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">9147000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">2948000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">2020000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">1478000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1844000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">316000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31_custom_PersonnelExpensesMember" unitRef="EUR" decimals="-3">1134000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31_custom_LegalAndConsultingFeesMember" unitRef="EUR" decimals="-3">394000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">6828000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">1479000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">566000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">10433000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">130000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">8250000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="-3">2183000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2017-01-01to2017-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="-3">130000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2016-01-01to2016-12-31_custom_InterestIncomeeMember" unitRef="EUR" decimals="-3">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2018-01-01to2018-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2017-01-01to2017-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2017-01-01to2017-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2016-01-01to2016-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="From2016-01-01to2016-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">1000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">2731000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">4923000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">2049000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">2624000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2018-01-01to2018-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">107000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2017-01-01to2017-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">2358000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2017-01-01to2017-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">2565000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2016-01-01to2016-12-31_custom_ForeignExchangesMember" unitRef="EUR" decimals="-3">3000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="From2016-01-01to2016-12-31_custom_FinanceIncomeCostOtherMember" unitRef="EUR" decimals="-3">2046000</ifrs-full:FinanceCosts>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">7702000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-4793000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-2048000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-29815000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-24238000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-8939000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-29815000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-24238000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2017-01-01to2017-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-24238000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-29815000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-8939000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="From2016-01-01to2016-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-8939000</ifrs-full:ProfitLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">51000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-29764000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-24238000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2017-01-01to2017-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-24238000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-29815000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-8939000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2016-01-01to2016-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-8939000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">51000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">223000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">41000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">207000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">20000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">1055000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">234000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">55386000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">123282000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2016-12-31" unitRef="EUR" decimals="-3">29117000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2015-12-31" unitRef="EUR" decimals="-3">3302000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">158159000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">123979000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">159214000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">124213000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">3116000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">2858000</ifrs-full:IssuedCapital>
    <ifrs-full:OtherReserves contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">18310000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">6225000</ifrs-full:OtherReserves>
    <ifrs-full:RetainedEarnings contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">-81107000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">-51293000</ifrs-full:RetainedEarnings>
    <ifrs-full:TreasuryShares contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">-50000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:TreasuryShares>
    <ifrs-full:Equity contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">151391000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">119429000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">31000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">2857000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">3116000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-27055000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-51293000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-81107000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31" unitRef="EUR" decimals="-3">-25690000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">1325000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">6225000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">18310000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">31000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">457000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31_ifrs-full_RetainedEarningsMember" unitRef="EUR" decimals="-3">-18116000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31" unitRef="EUR" decimals="-3">-17619000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">161639000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">211022000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2016-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">9000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2017-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">0</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">50000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2015-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">9000</ifrs-full:Equity>
    <ifrs-full:Provisions contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">57000</ifrs-full:Provisions>
    <ifrs-full:Provisions contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">2000</ifrs-full:Provisions>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">68000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">17000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">6657000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">4469000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">7756000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">4766000</ifrs-full:CurrentLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">159214000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">124213000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">12085000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">4550000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">868000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <IFRX:IssuedShareCapital contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-53443000</IFRX:IssuedShareCapital>
    <IFRX:IssuedShareCapital contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-90904000</IFRX:IssuedShareCapital>
    <IFRX:IssuedShareCapital contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</IFRX:IssuedShareCapital>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-3801000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-9115000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">-9115000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">-3801000</ifrs-full:ShareIssueRelatedCost>
    <IFRX:LiquidationOfSubsidiary contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-9000</IFRX:LiquidationOfSubsidiary>
    <IFRX:ReorganizationEquity contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">83026000</IFRX:ReorganizationEquity>
    <IFRX:ReorganizationEquity contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">1979000</IFRX:ReorganizationEquity>
    <IFRX:ReorganizationEquity contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">80698000</IFRX:ReorganizationEquity>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">174000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">71000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">33000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">421000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">24000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-2000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">2188000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">2917000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1181000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">1679000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">66000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">212000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-23712000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-12152000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-4992000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">806000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">149000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">53000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">210000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">19000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-99451000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-167000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-53000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssueOfPreferenceShares contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:ProceedsFromIssueOfPreferenceShares>
    <ifrs-full:ProceedsFromIssueOfPreferenceShares contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">27012000</ifrs-full:ProceedsFromIssueOfPreferenceShares>
    <ifrs-full:ProceedsFromIssueOfPreferenceShares contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">30860000</ifrs-full:ProceedsFromIssueOfPreferenceShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">49642000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">108801000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">30860000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">5626000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-2317000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:OtherIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">304000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">116000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">238000</ifrs-full:OtherIncome>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">17184000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">7629000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">248000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2017-01-01to2017-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">0</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="-3">4501000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2017-01-01to2017-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="-3">2897000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="-3">350000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2017-01-01to2017-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="-3">182000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">2462000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2016-01-01to2016-12-31_custom_OtherExpensesMember" unitRef="EUR" decimals="-3">0</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2016-01-01to2016-12-31_custom_WagesAndSalariesMember" unitRef="EUR" decimals="-3">1467000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2016-01-01to2016-12-31_custom_SocialSecurityMember" unitRef="EUR" decimals="-3">126000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2018-01-01to2018-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">12085000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2017-01-01to2017-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">4550000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="From2016-01-01to2016-12-31_custom_StockbasedCompensationExpenseMember" unitRef="EUR" decimals="-3">868000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">8715000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">7560000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">2729000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-8715000</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-7560000</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-2729000</IFRX:TaxLossesForWhichNoDeferredIncomeTaxAssetWasRecognized>
    <IFRX:TaxLossCarryforward contextRef="AsOf2018-12-31_custom_InflarxNVMember" unitRef="EUR" decimals="-3">33571000</IFRX:TaxLossCarryforward>
    <IFRX:TaxLossCarryforward contextRef="AsOf2017-12-31_custom_InflarxNVMember" unitRef="EUR" decimals="-3">7923000</IFRX:TaxLossCarryforward>
    <IFRX:TaxLossCarryforward contextRef="AsOf2018-12-31_custom_InflarxGmbHMember" unitRef="EUR" decimals="-3">34787000</IFRX:TaxLossCarryforward>
    <IFRX:TaxLossCarryforward contextRef="AsOf2017-12-31_custom_InflarxGmbHMember" unitRef="EUR" decimals="-3">34787000</IFRX:TaxLossCarryforward>
    <ifrs-full:BankBalancesAtCentralBanksOtherThanMandatoryReserveDeposits contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">22468000</ifrs-full:BankBalancesAtCentralBanksOtherThanMandatoryReserveDeposits>
    <ifrs-full:BankBalancesAtCentralBanksOtherThanMandatoryReserveDeposits contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">3177000</ifrs-full:BankBalancesAtCentralBanksOtherThanMandatoryReserveDeposits>
    <IFRX:UsdTermDeposits contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">32919000</IFRX:UsdTermDeposits>
    <IFRX:UsdTermDeposits contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">81229000</IFRX:UsdTermDeposits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2017-01-01to2017-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">1987000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">2524000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2016-01-01to2016-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">604000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2017-01-01to2017-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">81000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">238000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="From2016-01-01to2016-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">0</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2017-01-01to2017-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">3187000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">9801000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2016-01-01to2016-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">660000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2017-01-01to2017-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">43000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">1086000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="From2016-01-01to2016-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">208000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">13649000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">5298000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">1472000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2017-01-01to2017-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">5174000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">12325000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2016-01-01to2016-12-31_custom_ExecutiveManagementMember" unitRef="EUR" decimals="-3">1264000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2017-01-01to2017-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">124000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2018-01-01to2018-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">1324000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="From2016-01-01to2016-12-31_custom_NonExecutiveBoardOfDirectorsMember" unitRef="EUR" decimals="-3">208000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">25095</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">9411</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="From2016-01-01to2016-12-31" unitRef="Shares" decimals="INF">2363</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">-1.19</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">-2.60</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="From2016-01-01to2016-12-31" unitRef="USDPShares" decimals="INF">-3.80</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">-1.19</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">-2.60</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare contextRef="From2016-01-01to2016-12-31" unitRef="USDPShares" decimals="INF">-3.80</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">625000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">173000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:SharePremium contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">211022000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">161639000</ifrs-full:SharePremium>
    <ifrs-full:NoncurrentGovernmentGrants contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">11000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">15000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">310000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">2000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">788000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">295000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:Liabilities contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">7824000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">4783000</ifrs-full:Liabilities>
    <IFRX:DisclosureOfUnrecognizedItemsExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(a) Operating lease obligations&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group leases various properties,&#13;laboratory and office equipment and cars. Rental contracts are typically made for fixed periods of one to three years but may have&#13;renewal options. The lease agreements do not impose any covenants, but leased assets may not be used as security for borrowing&#13;purposes.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Commitments for minimum lease payments in relation to non-cancellable operating leases:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;473&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;292&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;575&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Rental expense relating to operating leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;162&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;213&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Contingent rentals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Sub-lease income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;162&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;213&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Operating lease obligations consist of&#13;payments pursuant to non-cancellable operating lease agreements mainly relating to the Company`s leases of office space. The lease&#13;term of the Company`s premises expires in the next three years: Jena, Germany in December 2019, Planegg, Germany in July 31, 2021&#13;respectively June 30, 2022 and Ann Arbor, United States in April 14, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(b) Other Commitments&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Commitments for minimum payments in relation to non-cancellable operating contracts or services:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,437&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19,624&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,684&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;7&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;4,532&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;29,307&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group enters into contracts in the&#13;normal course of business with Contract Research Organizations (&amp;#8216;CROs&amp;#8217;) and clinical sites for the conduct of clinical&#13;trials, professional consultants for expert advice and other vendors for clinical supply manufacturing or other services. Most&#13;of these contracts are not included in the table above as they provide for termination on notice, and therefore are cancelable&#13;contracts and do not include any minimum purchase commitments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;During 2018, the Group did not enter&#13;into contracts to purchase property, plant and equipment or patents and trademarks (respectively nil in 2017).&lt;/p&gt;</IFRX:DisclosureOfUnrecognizedItemsExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated financial statements&#13;of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and interpretations issued&#13;by the IFRS Interpretations Committee (IFRS IC) applicable to companies reporting under IFRS. The financial statements comply with&#13;IFRS as issued by the International Accounting Standards Board (IASB).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The financial statements have been prepared&#13;on a historical cost basis except for share-based payments which are measured at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These financial statements are consolidated&#13;financial statements for the Group consisting of InflaRx N.V. and its subsidiaries. The financial statements are presented in euro&#13;(&amp;#8364;). Euro is also the functional currency of InflaRx N.V.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All financial information presented in&#13;Euro has been rounded to the nearest thousand. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic&#13;aggregation of the figures that precede them or may deviate from other tables by one thousand euros at a maximum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Subsidiaries are all entities over which&#13;the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement&#13;with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries&#13;are fully consolidated from the date on which control is obtained by the Group. They are deconsolidated from the date control ceases.&#13;The acquisition method of accounting is used to account for business combinations by the Group. Intercompany transactions, balances&#13;and unrealized gains on transactions between Group companies are eliminated. Unrealized losses are also eliminated unless the transaction&#13;provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary&#13;to ensure consistency with the accounting policies adopted by the Group.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The financial statements were authorized&#13;for issue by the board of directors on March [&amp;#8226;], 2019. All press releases, financial reports and other information are available&#13;on the Investor on the Company`s website: www.inflarx.com&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has applied the following standards&#13;and amendments for the first time for their annual reporting period commencing January 1, 2018:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 9 Financial Instruments&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 15 Revenue from Contracts with Customers&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to IFRS 2 - Classification and Measurement of Share-based Payments&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Annual Improvements 2014-2016 cycle&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Transfers to Investment Property &amp;#8211; Amendments to IAS 40&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Interpretation 22 Foreign Currency Transactions and Advance Consideration&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has not early adopted any other&#13;standard, interpretation or amendment that has been issued but is not yet effective.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies in the financial statements,&#13;for the first time, IFRS 15 Revenue from Contracts with Customers and IFRS 9 Financial Instruments, which require restatement of&#13;previous financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 15, Revenue from Contracts with&#13;Customers, replaces all current standards and interpretations dealing with revenue recognition and introduces a five-step model&#13;to account for revenue. As the Group is currently not generating revenues, the Group may only be affected by IFRS 15 in the future&#13;when entering into collaboration arrangements or similar transactions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 9 contains a new classification&#13;and measurement approach for financial assets that reflects the business model in which assets are managed and their cash flow&#13;characteristics. IFRS 9 further replaces the &amp;#8216;incurred loss&amp;#8217; model in IAS 39 with a forward&lt;font style="font-family: Cambria Math,serif"&gt;-&lt;/font&gt;looking&#13;&amp;#8216;expected credit loss&amp;#8217; (ECL) model. This will require considerable judgement about how changes in economic factors&#13;affect ECLs, which will be determined on a probability&lt;font style="font-family: Cambria Math,serif"&gt;-&lt;/font&gt;weighted basis. IFRS&#13;9 requires new disclosures, in particular about credit risk and expected credit losses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies IFRS 9 with an initial&#13;application date of January 1, 2018. Because the Group held on the initial application date only immaterial non-current financial&#13;assets, cash and cash equivalents, no trade receivables and no derivative financial instruments or financial liabilities, the impact&#13;of IFRS 9 is determined to be nil, except for the disclosures required. Classification for other receivables and cash and cash&#13;equivalents changed from &amp;#8220;loans and receivables&amp;#8221; (IAS 39) to &amp;#8220;amortized cost&amp;#8221; (IFRS 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The impact of IFRS&amp;#160;9 in the absence&#13;of material financial instruments was nil. A restatement of the consolidated statement of financial position as at January 1, 2018&#13;was not necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Most of the other amendments listed above&#13;did not have any impact on the amounts recognized in prior periods and are not expected to significantly affect the current or&#13;future periods.&lt;/p&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <IFRX:DescriptionOfAccountingPolicyNewStandardsAndInterpretationsNotYetAdoptedExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Certain new accounting standards and&#13;interpretations have been published that are not mandatory for December 31, 2018 reporting periods and have not been early adopted&#13;by the Group. The Group&amp;#8217;s assessment of the impact of these new standards and interpretations is set out below.&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRIC 23 Uncertainty over Tax Treatments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Prepayment Features with Negative Compensation (Amendments to IFRS 9).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Long-term Interests in Associates and Joint Ventures (Amendments to IAS 28).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Plan Amendment, Curtailment or Settlement (Amendments to IAS 19).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Annual Improvements to IFRS Standards 2015&amp;#8211;2017 Cycle &amp;#8211; various standards.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Amendments to References to Conceptual Framework in IFRS Standards.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 17 Insurance Contracts.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;IFRS 16 Leases.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 16 was issued in January 2016. It&#13;will result in almost all leases being recognized on the balance sheet by lessees, as the distinction between operating and finance&#13;leases is removed. Under the new standard, an asset (the right to use the leased item) and a financial liability to pay rentals&#13;are recognized. The only exceptions are short-term and low-value leases.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has analyzed all of the Group&amp;#8217;s&#13;leasing arrangements over the last year in light of the new lease accounting rules in IFRS 16.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As at the reporting date, the Group has&#13;non-cancellable operating lease commitments of &amp;#8364;575 thousand (see &amp;#8216;3.&amp;#160;Unrecognized items - (a) Operating lease&#13;obligations&amp;#8217;). Of these commitments, approximately &amp;#8364;10 thousand relate to short-term leases and &amp;#8364;6 thousand to&#13;low value leases which will both be recognized on a straight-line basis as expense in profit or loss. For the remaining lease commitments,&#13;the Group expects to recognize right-of-use assets of approximately &amp;#8364;791 thousand on January 1, 2019, lease liabilities of&#13;&amp;#8364;791 thousand (after adjustments for prepayments and accrued lease payments recognized as at December 31, 2018). Overall&#13;net assets will stay approximately the same, and net current assets will be &amp;#8364;240 thousand lower due to the presentation of&#13;a portion of the liability as a current liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group expects that net loss will&#13;decrease by approximately &amp;#8364;5 thousand for 2019 as a result of adopting IFRS&amp;#160;16. Operating cash flows will increase and&#13;financing cash flows decrease by approximately &amp;#8364;240 thousand as repayment of the principal portion of the lease liabilities&#13;will be classified as cash flows from financing activities.&lt;/p&gt;</IFRX:DescriptionOfAccountingPolicyNewStandardsAndInterpretationsNotYetAdoptedExplanatory>
    <IFRX:DescriptionOfAccountingPolicyCurrentAndNoncurrentDistinctionExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group presents current and non-current&#13;assets and current and non-current liabilities as separate classifications in its balance sheet. Current assets include assets&#13;that are sold, consumed or realized as part of the normal operating cycle. The operating cycle of an entity is the time between&#13;the acquisition of assets for processing and their realization in the form of cash or cash equivalents. The Groups operating cycle&#13;is assumed to be 12 months. Some current liabilities, such as trade payables and some accruals for employee and other operating&#13;costs, are part of the working capital used in the entity&amp;#8217;s normal operating cycle. Such operating items are classified as&#13;current liabilities even if they are due to be settled more than 12 months after the reporting period.&lt;/p&gt;</IFRX:DescriptionOfAccountingPolicyCurrentAndNoncurrentDistinctionExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Transactions in a foreign currency are&#13;initially translated into the respective functional currency using the spot rate prevailing on the dates of the transaction. Monetary&#13;items which are not denominated in the functional currency are subsequently translated using the rate applicable at the end of&#13;the period. The resulting currency gains and losses are recognized directly in profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On consolidation, the assets and liabilities&#13;of foreign operations are translated into euros at the rate of exchange prevailing at the reporting date and their statements of&#13;profit or loss are translated with monthly average exchange rates during the reporting period. The exchange differences arising&#13;on translation for consolidation are recognized in other comprehensive income (OCI). On disposal of a foreign operation, the component&#13;of OCI relating to that particular foreign operation is reclassified to profit or loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development expenses comprise&#13;third party services, wages and salaries, cost of materials, intellectual property related expenses, depreciation and amortization&#13;of relevant equipment and intangibles as well as overhead. Research and development expenses mainly consist of cost for clinical&#13;trials and manufacturing of our clinical drug product, additionally cost are incurred by pre-clinical activities as well as basic&#13;research activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Development expenses must be capitalized&#13;if the criteria of IAS 38 are met. In the periods presented, no development expenses were capitalized because management does not&#13;believe all the recognition criteria of IAS 38 had been met. This assessment is due to the general uncertainties in drug development&#13;and the unpredictability of regulatory requirements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As research expenditure and development&#13;expenditure does not meet the recognition criteria they are treated as an expense when incurred. Development costs previously recognized&#13;as an expense are not recognized as an asset in a subsequent period.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;(i) Short-term employee benefits &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Liabilities for wages and salaries and&#13;cash bonuses are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as&#13;current employee benefit obligations in the balance sheet. A liability is recognized, if the Group has a present legal or constructive&#13;obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated reliably.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;(ii) Share-based payment transactions &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The grant-date fair value of equity-settled&#13;share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity,&#13;over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which&#13;the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is&#13;based on the number of awards that meet the related service and non- market performance conditions at the vesting date. For share-based&#13;payment awards with immediate vesting, the grant-date fair value of the share-based payment is measured to reflect such conditions&#13;and there is no true-up for differences between expected and actual outcomes.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group received government grants&#13;in 2018 and prior years on certain investments in non-current assets and the Group still receives grant funds on specified research&#13;and development activities. Income from government grants is recognized under &amp;#8216;other income&amp;#8217; in the consolidated statement&#13;of comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income from the government grants is&#13;recognized at fair value where there is a reasonable assurance that the grant will be received and the Group will comply with all&#13;attached terms and conditions. In prior years grants were collected together with investments in non-current assets, the income&#13;was deferred on a straight-line basis over the useful lives of the respective assets. Contributions supporting certain costs of&#13;research and development are recognized as income when respective reimbursable costs also are incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group leases various properties,&#13;laboratory and office equipment and cars. Rental contracts are typically made for fixed periods of one to five years but may have&#13;renewal options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The lease is classified at the inception&#13;date as a finance lease or an operating lease. A lease that transfers substantially all the risks and rewards incidental to ownership&#13;to the Group is classified as a finance lease. Typically the Group&amp;#8217;s contracts are falling under the criteria of operate&#13;leases.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;An operating lease is a lease other than&#13;a finance lease. Operating lease payments are recognized as an operating expense in the statement of profit or loss on a straight-line&#13;basis over the lease term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Finance leases are capitalized at the&#13;commencement of the lease at the inception date fair value of the leased property or, if lower, at the present value of the minimum&#13;lease payments. Lease payments are apportioned between finance charges and reduction of the lease liability so as to achieve a&#13;constant rate of interest on the remaining balance of the liability. Finance charges are recognized in finance costs in the statement&#13;of profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A leased asset is depreciated over the&#13;useful life of the asset. However, if there is no reasonable certainty that the Group will obtain ownership by the end of the lease&#13;term, the asset is depreciated over the shorter of the estimated useful life of the asset and the lease term.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is derived from interest-bearing&#13;financial assets, including cash equivalents. Interest income from financial assets at fair value through profit and loss is included&#13;in the net fair value gains/(losses) on these assets. Interest income on cash and cash equivalents, financial assets at amortized&#13;cost calculated using the effective interest method is recognized in the statement of profit or loss as part of finance income.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Intangible assets mainly comprise purchased&#13;IT software. Intangible assets are initially measured at acquisition cost, including any directly attributable costs of preparing&#13;the asset for its intended use less accumulated amortization. Amortization begins when an asset is available for use and amortization&#13;is calculated using the straight-line method to allocate cost over the estimated useful lives. Software is amortized over three&#13;years. The useful lives of intangible assets are reviewed at each reporting date. The effect of any adjustment to useful lives&#13;is recognized prospectively as a change of accounting estimate. The Group only owns intangible assets with a definite useful life.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Laboratory and office equipment are stated&#13;at historical cost less accumulated depreciation. Historical cost includes expenditure that is directly attributable to the acquisition&#13;of the items.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All repairs and maintenance are charged&#13;to profit or loss during the financial period in which they are incurred, because they do not constitute a separate asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Depreciation on leasehold improvements&#13;and equipment is calculated using the straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 8.8pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Laboratory equipment: three to 13 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 8.8pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Office equipment: one to five years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The assets&amp;#8217; residual values and&#13;useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on disposals are determined&#13;by comparing the proceeds with the carrying amount and are recognized within &amp;#8216;other income and expenses (net)&amp;#8217; in the&#13;consolidated statement of other comprehensive loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A financial instrument is any contract&#13;that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s financial liabilities&#13;comprise trade and other payables. The Group initially recognizes non- derivative financial liabilities on the date that they are&#13;originated and measures them at amortized cost using the effective interest rate method. The Group derecognizes a financial liability&#13;when its contractual obligations are discharged, cancelled or expire.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income taxes comprise current and deferred&#13;taxes. Current and deferred taxes are recognized in profit or loss except to the extent that they relate to items recognized directly&#13;in equity or in other comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current tax is the expected tax payable&#13;or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date,&#13;and any adjustment to tax payable in respect of previous years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is recognized in respect&#13;of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts&#13;used for taxation purposes. Deferred tax is not recognized for temporary differences associated with assets and liabilities if&#13;the transaction which led to their initial recognition is a transaction that is not a business combination and that affects neither&#13;accounting nor tax profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is measured at the tax rates&#13;that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively&#13;enacted by the reporting date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax assets and liabilities are&#13;presented net if there is a legally enforceable right to offset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A deferred tax asset is recognized for&#13;unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits&#13;will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to&#13;the extent that it is no longer probable that the related tax benefit will be realized. Unrecognized deferred tax assets are reassessed&#13;at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against&#13;which they can be used.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Due to its stage of development, the&#13;Company does not report deferred tax assets on its consolidated statement of financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A number of the Group&amp;#8217;s accounting&#13;policies and disclosures require the measurement of fair values, for both financial and non-financial assets and liabilities. When&#13;measuring the fair value of an asset or a liability, the Group uses observable market data as far as possible. Fair values are&#13;categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 8.8pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 1, quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 8.8pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 2, inputs other than quoted prices included within Level 1 that are observable for the instrument,&#13;either directly (as prices) or indirectly (derived from prices).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 8.8pt"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 8pt"&gt;Level 3, inputs for instruments that are not based on observable market data (unobservable inputs).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;If the inputs used to measure the fair&#13;value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized&#13;in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group recognizes transfers between&#13;levels of the fair value hierarchy at the end of the reporting period during which the change has occurred. Further information&#13;about the assumptions made in measuring fair values of share-based payments is included in &amp;#8220;1.&amp;#9;Equity settled share-based&#13;payment arrangements&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The carrying amount of all financial&#13;instruments approximates their fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <IFRX:SummaryOfResearchAndDevelopmentExpensesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 70%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 9.35pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Research and development expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Third-party services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,856&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,909&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;manufacturing&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;&amp;#8212;*&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;5,559&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;4,829&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;clinical, pre-clinical&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;&amp;#8212;*&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;3,297&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;11,080&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Personnel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,293&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,037&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;stock-based compensation expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;302&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;3,071&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;5,256&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;643&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;132&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;235&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;661&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;5,278&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;14,415&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;25,028&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfResearchAndDevelopmentExpensesTableTextBlock>
    <IFRX:SummaryOfGeneralAndAdministrativeExpensesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 67%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Personnel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,948&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,147&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;stock-based compensation expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;566&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;1,479&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;i&gt;6,828&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,478&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;316&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;712&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;1,619&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;1,844&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;5,138&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;12,787&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfGeneralAndAdministrativeExpensesTableTextBlock>
    <IFRX:SummaryOfEmployeeBenefitsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 67%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Employee benefits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Wages and salaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,467&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,897&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,501&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Social Security contributions*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;182&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;350&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Stock-based compensation expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;868&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,550&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;12,085&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;248&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;2,462&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;7,629&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;17,184&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfEmployeeBenefitsTableTextBlock>
    <IFRX:SummaryOfFinanceCostsNetTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,183&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;1&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;-&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;130&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;10,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Finance costs&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Foreign exchange expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;2,046&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;2,565&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;107&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;2,049&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;4,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;2,731&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Net financial result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;(2,048)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;(4,793)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;7,702&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfFinanceCostsNetTableTextBlock>
    <IFRX:SummaryOfIncomeTaxesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx N.V.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;7,923&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;33,571&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;InflaRx GmbH&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;34,787&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;34,787&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Loss before taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(8,939)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(24,238)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(29,815)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.5%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;31.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;29.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax benefits at tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,729&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,715&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Tax losses for which no deferred tax asset was recognized&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;(2,729)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;(7,560)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;(8,715)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="3" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;</IFRX:SummaryOfIncomeTaxesTableTextBlock>
    <IFRX:SummaryOfOtherAssetsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; font: bold 8pt/9pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;504&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,047&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;192&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;542&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;696&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;1,589&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfOtherAssetsTableTextBlock>
    <IFRX:SummaryOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Trade and other payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(4,469)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(6,657)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-bottom: 10pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
    <IFRX:SummaryOfCashAndCashEquivalentsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; font: bold 8pt/9pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Short-term deposits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;81,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;32,919&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Deposits held in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;38,876&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;120,105&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;32,919&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cash at banks&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Money held in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,842&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;21,720&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Money held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;335&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;748&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;3,177&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;22,468&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;123,282&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;55,386&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfCashAndCashEquivalentsTableTextBlock>
    <IFRX:SummaryOfFinancialRiskManagementTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="width: 13%; border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 35%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Measurement&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 32%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Risk Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Future development costs; Recognized financial assets and liabilities not denominated in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Forecasted cash flows Sensitivity analysis&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Achievement of a natural hedge&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;in the future&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Cash and cash equivalents,&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;debt investments&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Credit&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;rating&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Diversification of bank deposits, Investment&#13;        guidelines for&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;debt investments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;R&amp;#38;D and G&amp;#38;A cost&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;and trade payables&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Rolling&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;cash flow forecast&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Availability of funds through financing rounds or public offerings&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfFinancialRiskManagementTableTextBlock>
    <IFRX:SummaryOfAssetsExposedToRiskTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 89%; padding: 1pt 2.9pt 2pt; font: bold 8pt/9pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 9.35pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;101,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;55,386&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total assets exposed to the risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;156,777&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Conversion rate EUR/USD at reporting date 1/1.1450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfAssetsExposedToRiskTableTextBlock>
    <IFRX:SummaryOfSensitivityAnalysisTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Conversion&#13;        rate&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Profit/(loss)&#13;        in P&amp;#38;L&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;carrying&#13;        amount&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro weakens by 1% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.1565&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,552)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;155,225&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro strengths by 1% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.1336&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,584&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;158,361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro weakens by 5% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(7,466) &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;149,311&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro strengths by 5% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.0878&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;8,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;165,028&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro weakens by 10% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.2595&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(14,252)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;142,525&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: -2.85pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Euro strengths by 10% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.0305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,420&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;174,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfSensitivityAnalysisTableTextBlock>
    <IFRX:SummaryOfLiquidityRiskTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; font: bold 8pt/9pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;120,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;32,919&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Cash at banks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;3,177&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;22,468&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;123,282&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;55,386&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Marketable Securities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Securities and other Investments (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;100,868&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;100,868&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Other financial assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&lt;font style="font-size: 8pt"&gt;Other (non-current portion)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Other (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;316&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;20&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;523&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total funds available&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;123,302&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;156,777&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 10pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfLiquidityRiskTableTextBlock>
    <IFRX:SummaryOfOperatingLeaseObligationsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Commitments for minimum lease payments in relation to non-cancellable operating leases:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;283&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;473&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;292&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;575&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Rental expense relating to operating leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;162&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;213&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Contingent rentals&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Sub-lease income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;162&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;213&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfOperatingLeaseObligationsTableTextBlock>
    <IFRX:SummaryOfOtherCommitmentsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Commitments for minimum payments in relation to non-cancellable operating contracts or services:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;Within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,437&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19,624&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;After one year but not more than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,684&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;More than five years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;7&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;4,532&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;29,307&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfOtherCommitmentsTableTextBlock>
    <IFRX:SummaryOfSubsidiariesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border: Black 1pt solid; text-align: center; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Name&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Place of business/ country of incorporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Functional currency&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ownership interest held by the Group&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#9;2017 &amp;#9;2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal activities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 19%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx GmbH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Germany&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;EUR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 33%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Principal operating subsidiary, biopharmaceutical company&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx Pharmaceutical Inc.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;U.S.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;USD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;Subsidiary for basic research&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfSubsidiariesTableTextBlock>
    <IFRX:SummaryOfCompensationOfExecutiveManagementTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 67%; padding: 1pt 2.9pt 2pt; font: bold 8pt/9pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2016&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; font: bold 8pt/9pt Times New Roman, Times, Serif; padding: 1pt 2.9pt 2pt; text-align: center"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Executive Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;604&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,987&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;660&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;3,187&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;9,801&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;1,264&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;5,174&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;12,325&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Non-executive Board of Directors&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;81&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;238&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;208&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;43&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;1,086&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;208&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;124&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 0.5pt solid"&gt;&lt;b&gt;1,324&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 1.5pt double"&gt;&lt;b&gt;1,472&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 1.5pt double"&gt;&lt;b&gt;5,298&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 1.5pt double"&gt;&lt;b&gt;13,649&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfCompensationOfExecutiveManagementTableTextBlock>
    <IFRX:SummaryOfStockOptionsGrantedTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 50%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Q1-2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Q2-2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Q3-2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Q3-2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;Q4-2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: left; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;Parameters&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Fair value at grant date&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Per option (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;22.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;FX rate as of grant date&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.88&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Per option (EUR)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;11.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;19.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;16.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;11.75&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Share price at grant date (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;22.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;37.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;32.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;33.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26.02&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Exercise price (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;22.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;37.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;32.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;33.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;26.02&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.65&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Expected life (midpoint based)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="text-indent: 0in"&gt;&lt;font style="font-size: 8pt"&gt;Expected dividends&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"&gt;Risk-free rate&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"&gt;(interpolated, U.S. sovereign strips curve)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.0%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfStockOptionsGrantedTableTextBlock>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">22000</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</IFRX:ProceedsFromDisposalOfNoncurrentOtherFinancialAssets>
    <IFRX:ProceedsFromDisposalOfCurrentFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">7990000</IFRX:ProceedsFromDisposalOfCurrentFinancialAssets>
    <IFRX:ProceedsFromDisposalOfCurrentFinancialAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</IFRX:ProceedsFromDisposalOfCurrentFinancialAssets>
    <IFRX:ProceedsFromDisposalOfCurrentFinancialAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</IFRX:ProceedsFromDisposalOfCurrentFinancialAssets>
    <IFRX:EffectsOfExchangeRateChangesOnFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-2387000</IFRX:EffectsOfExchangeRateChangesOnFinancialAssets>
    <IFRX:EffectsOfExchangeRateChangesOnFinancialAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-61000</IFRX:EffectsOfExchangeRateChangesOnFinancialAssets>
    <IFRX:EffectsOfExchangeRateChangesOnFinancialAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</IFRX:EffectsOfExchangeRateChangesOnFinancialAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-894000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-523000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-74000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-316000</ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">154000</ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-22000</ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets>
    <ifrs-full:AdjustmentsForProvisions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">55000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:AdjustmentsForProvisions>
    <IFRX:AdjustmentsForGovernmentGrants contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-4000</IFRX:AdjustmentsForGovernmentGrants>
    <IFRX:AdjustmentsForGovernmentGrants contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-4000</IFRX:AdjustmentsForGovernmentGrants>
    <IFRX:AdjustmentsForGovernmentGrants contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-4000</IFRX:AdjustmentsForGovernmentGrants>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">493000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">129000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">113000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">310000</IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities>
    <IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-30000</IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities>
    <IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">18000</IFRX:AdjustmentsForIncreaseDecreaseInSocialSecuritiesAndOtherTaxLiabilities>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">61727000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">169355000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">2826000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">258000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">868000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">4900000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">12085000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2016-01-01to2016-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">868000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2017-01-01to2017-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">161638000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">49384000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:TransactionsWithOwnersOfCompany contextRef="From2017-01-01to2017-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">-9000</IFRX:TransactionsWithOwnersOfCompany>
    <IFRX:ChangesInOwnershipInterests contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">83017000</IFRX:ChangesInOwnershipInterests>
    <IFRX:ChangesInOwnershipInterests contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">1978000</IFRX:ChangesInOwnershipInterests>
    <IFRX:ChangesInOwnershipInterests contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">350000</IFRX:ChangesInOwnershipInterests>
    <IFRX:ChangesInOwnershipInterests contextRef="From2017-01-01to2017-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">80698000</IFRX:ChangesInOwnershipInterests>
    <IFRX:ChangesInOwnershipInterests contextRef="From2017-01-01to2017-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">-9000</IFRX:ChangesInOwnershipInterests>
    <ifrs-full:NoncurrentFinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">207000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">20000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">101184000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">-6657000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">-4469000</ifrs-full:TradeAndOtherPayables>
    <IFRX:DepositsHeldInEuro contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">0</IFRX:DepositsHeldInEuro>
    <IFRX:DepositsHeldInEuro contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">38876000</IFRX:DepositsHeldInEuro>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">32919000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">120105000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <IFRX:MoneyHeldInEuro contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">21720000</IFRX:MoneyHeldInEuro>
    <IFRX:MoneyHeldInEuro contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">2842000</IFRX:MoneyHeldInEuro>
    <IFRX:MoneyHeldInU.s.Dollars contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">748000</IFRX:MoneyHeldInU.s.Dollars>
    <IFRX:MoneyHeldInU.s.Dollars contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">335000</IFRX:MoneyHeldInU.s.Dollars>
    <IFRX:SummaryOfTaxLossCarryforwardsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 78%; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2017&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid"&gt;December&#13;        31, 2018&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding: 1pt 2.9pt 2pt; text-align: center; line-height: 9pt; font-size: 8pt; font-weight: bold"&gt;(in thousands of &amp;#8364;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;InflaRx N.V.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;7,923&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;33,571&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;InflaRx GmbH&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;34,787&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;34,787&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-indent: 0in; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</IFRX:SummaryOfTaxLossCarryforwardsTableTextBlock>
    <IFRX:RiskExposure contextRef="From2018-01-01to2018-12-31_ifrs-full_MarketRiskMember">Future development costs; Recognized financial assets and liabilities not denominated in euro</IFRX:RiskExposure>
    <IFRX:RiskExposure contextRef="From2018-01-01to2018-12-31_ifrs-full_CreditRiskMember">Cash and cash equivalents, debt investments</IFRX:RiskExposure>
    <IFRX:RiskExposure contextRef="From2018-01-01to2018-12-31_custom_LiquidityMember">R&amp;D and G&amp;A cost and trade payables</IFRX:RiskExposure>
    <IFRX:RiskMeasurement contextRef="From2018-01-01to2018-12-31_ifrs-full_MarketRiskMember">Forecasted cash flows Sensitivity analysis</IFRX:RiskMeasurement>
    <IFRX:RiskMeasurement contextRef="From2018-01-01to2018-12-31_ifrs-full_CreditRiskMember">Credit rating</IFRX:RiskMeasurement>
    <IFRX:RiskMeasurement contextRef="From2018-01-01to2018-12-31_custom_LiquidityMember">Rolling cash flow forecast</IFRX:RiskMeasurement>
    <IFRX:RiskManagement contextRef="From2018-01-01to2018-12-31_ifrs-full_MarketRiskMember">Achievement of a natural hedge in the future</IFRX:RiskManagement>
    <IFRX:RiskManagement contextRef="From2018-01-01to2018-12-31_ifrs-full_CreditRiskMember">Diversification of bank deposits, Investment guidelines for debt investments</IFRX:RiskManagement>
    <IFRX:RiskManagement contextRef="From2018-01-01to2018-12-31_custom_LiquidityMember">Availability of funds through financing rounds or public offerings</IFRX:RiskManagement>
    <IFRX:AssetsExposedToRisk contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">156777000</IFRX:AssetsExposedToRisk>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_OnePercentIncreaseMember" unitRef="EURPerUSD" decimals="INF">1.1336</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_OnePercentDecreaseMember" unitRef="EURPerUSD" decimals="INF">1.1565</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_FivePercentIncreaseMember" unitRef="EURPerUSD" decimals="INF">1.0878</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_FivePercentDecreaseMember" unitRef="EURPerUSD" decimals="INF">1.2023</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_TenPercentIncreaseMember" unitRef="EURPerUSD" decimals="INF">1.0305</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="AsOf2018-12-31_custom_TenPercentDecreaseMember" unitRef="EURPerUSD" decimals="INF">1.2595</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_OnePercentIncreaseMember" unitRef="EUR" decimals="-3">1584000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_OnePercentDecreaseMember" unitRef="EUR" decimals="-3">-1552000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_FivePercentIncreaseMember" unitRef="EUR" decimals="-3">8251000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_FivePercentDecreaseMember" unitRef="EUR" decimals="-3">-7466000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_TenPercentIncreaseMember" unitRef="EUR" decimals="-3">17420000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="From2018-01-01to2018-12-31_custom_TenPercentDecreaseMember" unitRef="EUR" decimals="-3">-14252000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_OnePercentIncreaseMember" unitRef="EUR" decimals="-3">158361000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_OnePercentDecreaseMember" unitRef="EUR" decimals="-3">155225000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_FivePercentIncreaseMember" unitRef="EUR" decimals="-3">165028000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_FivePercentDecreaseMember" unitRef="EUR" decimals="-3">149311000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_TenPercentIncreaseMember" unitRef="EUR" decimals="-3">174197000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2018-12-31_custom_TenPercentDecreaseMember" unitRef="EUR" decimals="-3">142525000</ifrs-full:Cash>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">22468000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">3177000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">316000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">523000</ifrs-full:OtherFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">20000</ifrs-full:OtherFinancialAssets>
    <IFRX:FundsAvailable contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">156777000</IFRX:FundsAvailable>
    <IFRX:FundsAvailable contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">123302000</IFRX:FundsAvailable>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">575000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">717000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2018-12-31_custom_WithinOneYearMember" unitRef="EUR" decimals="-3">283000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2018-12-31_custom_MoreThanFiveYearsMember" unitRef="EUR" decimals="-3">0</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2018-12-31_custom_OneToFiveYearsMember" unitRef="EUR" decimals="-3">292000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2017-12-31_custom_WithinOneYearMember" unitRef="EUR" decimals="-3">244000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2017-12-31_custom_OneToFiveYearsMember" unitRef="EUR" decimals="-3">473000</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease contextRef="AsOf2017-12-31_custom_MoreThanFiveYearsMember" unitRef="EUR" decimals="-3">0</ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">29307000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">4532000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2018-12-31_custom_WithinOneYearMember" unitRef="EUR" decimals="-3">19624000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2018-12-31_custom_MoreThanFiveYearsMember" unitRef="EUR" decimals="-3">0</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2018-12-31_custom_OneToFiveYearsMember" unitRef="EUR" decimals="-3">9684000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2017-12-31_custom_WithinOneYearMember" unitRef="EUR" decimals="-3">4437000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2017-12-31_custom_OneToFiveYearsMember" unitRef="EUR" decimals="-3">88000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements contextRef="AsOf2017-12-31_custom_MoreThanFiveYearsMember" unitRef="EUR" decimals="-3">7000</ifrs-full:MinimumLeasePaymentsOfArrangementsThatIncludePaymentsForNonleaseElements>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">213000</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">162000</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2018-01-01to2018-12-31_custom_MinimumLeasePaymentsMember" unitRef="EUR" decimals="-3">213000</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2018-01-01to2018-12-31_custom_ContingentRentalsMember" unitRef="EUR" decimals="-3">0</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2017-01-01to2017-12-31_custom_MinimumLeasePaymentsMember" unitRef="EUR" decimals="-3">162000</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2017-01-01to2017-12-31_custom_ContingentRentalsMember" unitRef="EUR" decimals="-3">0</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2018-01-01to2018-12-31_custom_SubleaseIncomeMember9747379" unitRef="EUR" decimals="-3">0</IFRX:RentalExpenseRelatingToOperatingLeases>
    <IFRX:RentalExpenseRelatingToOperatingLeases contextRef="From2017-01-01to2017-12-31_custom_SubleaseIncomeMember9747426" unitRef="EUR" decimals="-3">0</IFRX:RentalExpenseRelatingToOperatingLeases>
    <ifrs-full:CountryOfIncorporation contextRef="From2018-01-01to2018-12-31_custom_InflarxNVMember">Germany</ifrs-full:CountryOfIncorporation>
    <ifrs-full:CountryOfIncorporation contextRef="From2018-01-01to2018-12-31_custom_InflarxPharmaceuticalsIncMember">U.S.</ifrs-full:CountryOfIncorporation>
    <ifrs-full:DescriptionOfFunctionalCurrency contextRef="From2018-01-01to2018-12-31_custom_InflarxNVMember">EUR</ifrs-full:DescriptionOfFunctionalCurrency>
    <ifrs-full:DescriptionOfFunctionalCurrency contextRef="From2018-01-01to2018-12-31_custom_InflarxPharmaceuticalsIncMember">USD</ifrs-full:DescriptionOfFunctionalCurrency>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2018-01-01to2018-12-31_custom_InflarxNVMember" unitRef="Rate" decimals="INF">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2018-01-01to2018-12-31_custom_InflarxPharmaceuticalsIncMember" unitRef="Rate" decimals="INF">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2017-01-01to2017-12-31_custom_InflarxNVMember" unitRef="Rate" decimals="INF">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="From2017-01-01to2017-12-31_custom_InflarxPharmaceuticalsIncMember" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities contextRef="From2018-01-01to2018-12-31_custom_InflarxNVMember">Principal operating subsidiary, biopharmaceutical company</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities contextRef="From2018-01-01to2018-12-31_custom_InflarxPharmaceuticalsIncMember">Subsidiary for basic research</ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">626933</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">2051009</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">1869192</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">26256</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">208073</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="Rate" decimals="INF">0.0073</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="Rate" decimals="INF">0.0073</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="Rate" decimals="INF">0.0073</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="Rate" decimals="INF">0.0073</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="Rate" decimals="INF">0.0065</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <IFRX:ExercisePriceInUSD contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="USDPShares" decimals="INF">22.75</IFRX:ExercisePriceInUSD>
    <IFRX:ExercisePriceInUSD contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="USDPShares" decimals="INF">37.85</IFRX:ExercisePriceInUSD>
    <IFRX:ExercisePriceInUSD contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="USDPShares" decimals="INF">32.4</IFRX:ExercisePriceInUSD>
    <IFRX:ExercisePriceInUSD contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="USDPShares" decimals="INF">33.06</IFRX:ExercisePriceInUSD>
    <IFRX:ExercisePriceInUSD contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="USDPShares" decimals="INF">26.02</IFRX:ExercisePriceInUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="USDPShares" decimals="INF">22.75</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="USDPShares" decimals="INF">37.85</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="USDPShares" decimals="INF">32.4</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="USDPShares" decimals="INF">33.06</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:SharePriceAtGrantDateUSD contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="USDPShares" decimals="INF">26.02</IFRX:SharePriceAtGrantDateUSD>
    <IFRX:FairValuePerOptionEUR contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="EURPShares" decimals="INF">11.24</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="EURPShares" decimals="INF">19.23</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="EURPShares" decimals="INF">16.96</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="EURPShares" decimals="INF">17.15</IFRX:FairValuePerOptionEUR>
    <IFRX:FairValuePerOptionEUR contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="EURPShares" decimals="INF">11.75</IFRX:FairValuePerOptionEUR>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="Rate" decimals="INF">0.0082</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="Rate" decimals="INF">0.0086</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="Rate" decimals="INF">0.0086</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="Rate" decimals="INF">0.0085</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:ForeignExchangeRateAsOfGrantDate contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="Rate" decimals="INF">0.0088</IFRX:ForeignExchangeRateAsOfGrantDate>
    <IFRX:FairValuePerOptionUSD contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="USDPShares" decimals="INF">13.79</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="USDPShares" decimals="INF">22.37</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="USDPShares" decimals="INF">19.8</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="USDPShares" decimals="INF">20.17</IFRX:FairValuePerOptionUSD>
    <IFRX:FairValuePerOptionUSD contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="USDPShares" decimals="INF">13.39</IFRX:FairValuePerOptionUSD>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="Rate" xsi:nil="true" />
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q1Member" unitRef="Rate" decimals="INF">0.0260</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q2Member" unitRef="Rate" decimals="INF">0.0270</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q3Member" unitRef="Rate" decimals="INF">0.0280</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q31Member" unitRef="Rate" decimals="INF">0.0300</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2018-01-01to2018-12-31_custom_Q4Member" unitRef="Rate" decimals="INF">0.0290</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_Q1Member" unitRef="Rate" decimals="INF">4.9</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_Q2Member" unitRef="Rate" decimals="INF">4.6</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_Q3Member" unitRef="Rate" decimals="INF">4.9</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_Q31Member" unitRef="Rate" decimals="INF">4.9</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions contextRef="AsOf2018-12-31_custom_Q4Member" unitRef="Rate" decimals="INF">4</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(a) Critical estimates and judgements&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The preparation of the consolidated&#13;financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application&#13;of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these&#13;estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Estimates and underlying assumptions&#13;are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised&#13;and in any future periods affected.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In preparing these financial statements,&#13;the critical judgments made by management in applying the Group's accounting policies involve the determination of the grant date&#13;fair value of share-based payment awards see section &amp;#8216;4. Other information &amp;#8212; (d) Share-based payments&amp;#8217; as well&#13;as the measurement of R&amp;#38;D expenses that have to be accrued at period end for outstanding invoices (e.g. for pass-through costs&#13;charged by the Company&amp;#8217;s CROs).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(b) Financial risk management&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Financial&#13;risk management objectives and policies&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s risk management&#13;is predominantly controlled by central treasury activities under policies approved by the Board of Directors. Those treasury activities&#13;identify, evaluate and hedge financial risks in close co-operation with the Group&amp;#8217;s operating needs. The board provides policies&#13;for overall risk management, covering specific areas, such as foreign exchange risk and credit risk. The Company does not intend&#13;to use derivative financial instruments because the Group&amp;#8217;s future risk exposures cannot be reliably forecasted (volume of&#13;business activity, liquidity needs, foreign exchange exposure).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Hedge accounting is not applied&#13;as most of the business activity is intended to be executed in U.S. dollars and paid with the U.S. dollars funds raised in public&#13;offerings. The foreign exchange exposure from costs incurred in currencies other than euro is deemed immaterial and not worth hedging.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s principal financial&#13;assets comprise quoted debt securities with credit ratings range from AA- to AAA. Besides these financial assets, the Group has&#13;significant cash and cash equivalents. The Group&amp;#8217;s principal financial liabilities comprise trade payables. The main purpose&#13;of these financial assets, cash/cash equivalents and liabilities is to finance the Group&amp;#8217;s development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group is exposed to market&#13;risk, credit risk and liquidity risk. The Board of Directors reviews and adopts policies for managing each of these risks, which&#13;are summarized below. The Group&amp;#8217;s senior management oversees the management of these risks.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="width: 12%; border: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 37%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Measurement&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 31%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Risk Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Future development costs; Recognized financial assets and liabilities not denominated in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Forecasted cash flows Sensitivity analysis&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Achievement of a natural hedge&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;in the future&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Cash and cash equivalents,&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;debt investments&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Credit&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;rating&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Diversification of bank deposits, Investment&#13;        guidelines for&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;debt investments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;R&amp;#38;D and G&amp;#38;A cost&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;and trade payables&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Rolling&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;cash flow forecast&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; font: 11pt/107% Calibri, Helvetica, Sans-Serif; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Availability of funds through financing rounds or public offerings&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Market&#13;risk&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Market risk is the risk that changes&#13;in market prices (e.g. due to foreign exchange rates) will affect the Group&amp;#8217;s income, expenses or the value of its holdings&#13;of financial instruments. The objective of market risk management is to identify, manage and control market risk exposures within&#13;acceptable parameters.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group is exposed to transactional&#13;foreign currency risk to the extent that there is a mismatch between the currencies in which costs and purchases are denominated&#13;and the respective functional currencies of Group companies. The functional currencies of Group companies are primarily the euro&#13;and U.S. dollars. The currencies in which these transactions and financial assets are primarily denominated are euro and U.S. dollars.&#13;Currently the Group does not hedge U.S. dollars but intends to achieve a natural hedge by contracting suppliers in U.S. dollars&#13;in the future. In 2018 the Group recognized significant foreign exchange gains and losses as the natural hedge is not yet achieved&#13;and the functional currency for the major part of entities is euro.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group is primarily exposed&#13;to changes in U.S. dollars/euro exchange rates. The sensitivity of profit or loss to changes in the exchange rates arises mainly&#13;from U.S. dollar denominated financial instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In 2018, if the euro had weakened/strengthened&#13;by 10% against U.S. dollars with all other variables held constant, the Group`s loss would have been &amp;#8364;14.3 million higher/&amp;#8364;17.4&#13;million lower, mainly as a result of foreign exchange on translation of U.S. dollars-denominated assets.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 90%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 9.35pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;101,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;55,386&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total assets exposed to the risk&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;156,777&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Conversion rate EUR/USD at reporting date 1/1.1450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 8.65pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Sensitivity analysis:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Conversion&#13;        rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Profit/(loss)&#13;        in P&amp;#38;L&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;carrying&#13;        amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro weakens by 1% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.1565&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;(1,552)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;155,225&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro strengths by 1% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.1336&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,584&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;158,361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro weakens by 5% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;(7,466) &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;149,311&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro strengths by 5% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.0878&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;8,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;165,028&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro weakens by 10% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.2595&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;(14,252)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;142,525&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Euro strengths by 10% against U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1.0305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;17,420&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;174,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 64%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Credit&#13;risk&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The maximum exposure to counterparty&#13;credit risk is &amp;#8364;156.8 million in 2018 (2017: &amp;#8364;123.3 million). This amount equals the carrying amount of cash and cash&#13;equivalents (2018: &amp;#8364;55.4 million; 2017: &amp;#8364;123.3 million) plus. financial assets (2018: &amp;#8364;101.4 million; 2017: &amp;#8364;0&#13;million).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The cash and cash equivalents&#13;are held with banks, what are rated BBB to A based on Standard &amp;#38; Poor&amp;#8217;s and Moody&amp;#8217;s. The issuer of the money-market&#13;funds and other securities are graded in the top investment category (AA- to AAA) by credit rating agencies as S&amp;#38;P Global.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;4.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Liquidity&#13;risk&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Prudent liquidity risk management&#13;involves maintaining sufficient cash and marketable securities and the availability of funding to meet obligations when due. At&#13;the end of the reporting period the Group held the following deposits that are expected to readily generate cash inflows for managing&#13;liquidity risk.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 80%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Short-term deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;120,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;32,919&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Cash at banks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;3,177&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;22,468&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;123,282&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;55,386&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Marketable Securities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Securities and other Investments (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;100,868&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;&amp;#8212;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;100,868&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other financial assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Other (non-current portion)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Other (current)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;316&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;20&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;523&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total funds available&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;123,302&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;156,777&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group continually monitors&#13;its risk of a shortage of funds using short and mid-term liquidity planning. This takes into account of the expected cash flows&#13;from all activities. The management team performs regular reviews of the budget.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In November 2017 and May 2018,&#13;InflaRx raised significant funding that it estimates will enable the Group to fund operating expenses and capital expenditure requirements&#13;for at least the 12 months from December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group expects to require additional&#13;funding to continue to advance the development of product candidates. In the event regulatory approval is received and the Company&#13;implements a strategy to commercialize the products itself the Group would require additional capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(c) Capital management&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s policy for capital&#13;management is to ensure that it maintains its liquidity in order to finance its operating activities, future business development&#13;and meet its liabilities when due. The Group manages its capital structure primarily through equity. The Group does not have any&#13;financial debt, besides trade and other payables.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Under the 2017 long-term incentive&#13;plan the board and key employees may participate in the Group&amp;#8217;s share price development through long-term remuneration consisting&#13;of a stock option plan set up in 2017, please refer to &amp;#8216;4. Other information - (d) Share-based payments&amp;#8217;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;No changes were made in the objectives,&#13;policies or processes for managing capital during the year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(a) Reporting entity and Group&amp;#8217;s structure&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx N.V. is a Dutch public&#13;company with limited liability (naamloze vennootschap) with its corporate seat in Amsterdam, The Netherlands, and is registered&#13;in the Commercial Register of The Netherlands Chamber of Commerce Business Register under CCI number 68904312. The Company&amp;#8217;s&#13;registered office is at Winzerlaer Stra&amp;#223;e 2 in 07745 Jena, Germany. Since November 10, 2017, InflaRx N.V.&amp;#8217;s common shares&#13;have been listed on The NASDAQ Global Select Market under the symbol IFRX.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx is a clinical-stage biopharmaceutical&#13;Group focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors&#13;of the complement activation factor known as C5a.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These consolidated financial statements&#13;of InflaRx comprise the Company and its subsidiaries InflaRx GmbH, and, since January 5th, 2018, InflaRx Pharmaceutical Inc., Ann&#13;Arbor, Michigan/USA (together, the &amp;#8216;Group&amp;#8217;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(b) Material subsidiaries&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s principal subsidiaries&#13;at December 31, 2018 are set out below. Unless otherwise stated, they have share capital consisting solely of common shares that&#13;are held directly by the Group, and the proportion of ownership interests held equals the voting rights held by the Group. The&#13;country of incorporation or registration is also their principal place of business.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border: black 1pt solid; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Name&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Place of business/ country of incorporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Functional currency&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ownership interest held by the Group&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;2017 &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2018&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Principal activities&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 18%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;InflaRx GmbH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Germany&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;EUR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 36%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Principal operating subsidiary, biopharmaceutical company&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;InflaRx Pharmaceutical Inc.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;U.S.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;USD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;100%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Subsidiary for basic research&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx GmbH is a clinical-stage&#13;biopharmaceutical company founded in 2008. In 2017, InflaRx N.V. became the sole shareholder of InflaRx GmbH through the contribution&#13;of the subsidiary&amp;#8217;s shares to InflaRx N.V. by its existing shareholders in exchange of new shares issued by InflaRx N.V.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx Pharmaceutical Inc., a&#13;Delaware corporation, was founded on January 5, 2018 by InflaRx N.V.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(c) Related party transactions&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s executive management&#13;comprises the following persons:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Professor Niels C. Riedemann, Chief Executive Officer (CEO)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Professor Renfeng Guo, Chief Scientific Officer (CSO)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Arnd Christ, Chief Financial Officer (CFO)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Jason Marks, Chief Legal Officer, General Counsel (CLO), since January 1, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Othmar Zenker, Chief Medical Officer (CMO)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s board of directors&#13;comprises the following persons:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Executive Directors&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Professor Niels C. Riedemann, CEO&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Professor Renfeng Guo, CSO &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Non-executive Directors&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Nicolas Fulpius, Chairman, Chairman of the Audit Committee&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Jens Holstein, since September 21, 2018 Member of the Audit Committee&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Anthony Gibney, since February 6, 2018 Member of the Audit Committee&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Katrin Uschmann, Member of the Audit Committee until February 6, 2018&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Lina Ma&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Mark K&amp;#252;bler, Member of the Audit Committee until September 21, 2018&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-bottom: 10pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Richard Brudnick, Non-Voting Observer Director since February 14, 2019 , subject to the approval at the Annual General Meeting of Shareholders in May 2019. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The compensation of the Group&amp;#8217;s&#13;executive management comprises the following for the twelve months ending December 31:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 70%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Executive Management&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;604&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,987&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2,524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;660&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;3,187&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;9,801&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,264&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;5,174&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;12,325&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Non-executive Board of Directors&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Short-term employee benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;81&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;238&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Share-based payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;208&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;43&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;1,086&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;208&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;124&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,324&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 1.5pt double"&gt;&lt;b&gt;1,472&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 1.5pt double"&gt;&lt;b&gt;5,298&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 1.5pt double"&gt;&lt;b&gt;13,649&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 17.85pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Remuneration of InflaRx&amp;#8217;s&#13;executive management comprises fixed and variable components and share-based payment awards. In addition, the executive management&#13;receive supplementary benefits and allowances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;We entered into indemnification&#13;agreements with our directors and senior management. The indemnification agreements and our Articles of Association require us&#13;to indemnify our directors to the fullest extent permitted by law. See &amp;#8220;Item 6. Directors, Senior Management and Employees&amp;#8212;B.&#13;Compensation&amp;#8212;Insurance and indemnification&amp;#8221; for a description of these indemnification agreements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(d) Share-based payments&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Equity&#13;settled share-based payment arrangements&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the course of its historical&#13;financing rounds InflaRx GmbH established equity-settled share-based payment programs. Under these programs, the Company granted&#13;to its managing directors and senior executives options to acquire common shares. In total options covering 6,088 shares were granted.&#13;All of the options have vested. Those InflaRx GmbH options were converted into options covering 511,392 common shares of InflaRx&#13;N.V. at the initial public offering in November 2017. The exercise prices for each outstanding award is 0.01 &amp;#8364; per share&#13;or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Under the terms and conditions&#13;of the stock option plan 2016 InflaRx GmbH granted rights to subscribe for InflaRx GmbH&amp;#8217;s common shares to directors, senior&#13;management and key employees. Prior to the initial public offering, the outstanding awards under the 2016 plan covered an aggregate&#13;of 1,239,252 common shares and the exercise price for each outstanding award was &amp;#8364;7.81 per share (in each case after giving&#13;effect to the corporate reorganization in November 2017). Any additional awards available under the 2016 plan lapsed upon the closing&#13;of the Series D financing in October 2017. In 2016, InflaRx also established a share-based payment plan for its non-executive board&#13;members and granted options covering 484 shares. Grants under this plan were not subject to service or performance conditions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In conjunction with the closing&#13;of its initial public offering, InflaRx N.V. established a new plan (&amp;#8216;2017 long-term incentive plan&amp;#8216;).The initial maximum&#13;number of common shares available for issuance under equity incentive awards granted pursuant to the 2017 long term incentive plan&#13;equals 2,341,097 common shares. The number of share options under the plan was as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 90%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 9.35pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of stock options:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding at January 1, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,869,192&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Granted in 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;208,073&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Forfeited in 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;(26,256)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding at December 31, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2,051,009&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 0.25in; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;thereof vested&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;626,933&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 0.25in; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;thereof exercised&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;-&lt;/i&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the fourth quarter, of 2018&#13;75,000 stock options were awarded subject to a specified condition, which was satisfied in the first quarter of 2019, therefore,&#13;the expense for these stock options will occur in 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On January 1, 2021 and on January&#13;1 of each calendar year thereafter, an additional number of shares equal to 3% of the total outstanding common shares on December&#13;31 of the immediately preceding year (or any lower number of shares as determined by the board of directors) will become available&#13;for issuance under equity incentive awards granted pursuant to the &amp;#8216;2017 long-term incentive plan.&amp;#8216;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock options&#13;exercised&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In 2018 302,279 shares were issued&#13;following the exercise of stock options, resulting in proceeds to the Company of &amp;#8364;452.0 thousand. All stock options exercised&#13;were granted under the stock option plan 2016 and before.&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Measurement&#13;of fair values of stock options granted&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The fair value of options granted&#13;in 2018 under the 2017 long-term incentive plan was determined using the Black-Scholes valuation model. As the Company&amp;#8217;s&#13;common shares are listed on the Nasdaq Global Select Market, the closing price of the common shares at grant date was used. Other&#13;significant inputs into the model are as follows (weighted average):&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 50%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Q1-2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Q2-2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Q3-2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Q3-2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;Q4-2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Parameters&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Fair value at grant date&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Per option (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;13.79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;22.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;19.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;20.17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;13.39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;FX rate as of grant date&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.88&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Per option (EUR)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;11.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;19.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;16.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;17.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;11.75&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Share price at grant date (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;22.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;37.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;32.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;33.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;26.02&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Exercise price (USD)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;22.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;37.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;32.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;33.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;26.02&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;0.65&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Expected life (midpoint based)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;4.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;4.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Expected dividends&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Risk-free rate&lt;/p&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;(interpolated, U.S. sovereign strips curve)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;3.0%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Expected volatility has been based&#13;on an evaluation of the historical and implied volatility of a peer Group of companies The range of outcomes for the expected life&#13;of the instruments has been based on expectations on option holder behavior in the scenarios considered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The dividend yield has no impact&#13;due to the anti-dilution clause as defined in the LTI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 17.85pt"&gt;Expenses are determined based on the&#13;number of stock options granted within a tranche and the vesting period of a tranche. This implies two effects:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;the more options granted within a tranche, the higher expense of a tranche, and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;the shorter the vesting period of a tranche, the higher expense of a tranche.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;For example, 33.33% of all stock&#13;options granted are allocated to the first tranche which vests over 1 year after the Grant Date, whereas 8.33% of all stock options&#13;granted are allocated to the ninth tranche which vests over three years. Therefore the expenses recognized from the granted share&#13;options under the 2017 long-term incentive plan were &amp;#8364; nil in 2016, &amp;#8364;0.6 million in 2017, &amp;#8364;12.1 million for 2018&#13;and are anticipated to be &amp;#8364;4.9 million for 2019 and &amp;#8364;1.5 million for 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In the twelve month periods ending&#13;December 31, 2018, 2017 and 2016, compensation expense was recognized from the following plans:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;in 2018, &amp;#8364;12.1 million resulting solely from the 2017 long-term incentive plan,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;in 2017, &amp;#8364;0.6 million from the 2017 long-term incentive plan and another &amp;#8364;4.0 million resulting from 2016 option plan and the plans before,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 9px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;In 2016, &amp;#8364;0.9 million from 2016 option plan and the plans before.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;None of the share-based payments&#13;awards were dilutive in determining earnings per share due to the Group&amp;#8217;s loss position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(e) Loss per share&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Loss per common share is calculated&#13;by dividing the loss of the period by the weighted average number of common shares outstanding during the period. The weighted&#13;number of common shares outstanding for the financial year 2016 is 2,362,500, for 2017 is 9,410,524 common shares and for the financial&#13;year 2018 25,095,027 common shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(f) Protective foundation&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;According to the articles of association&#13;of the Company, up to 55,000,000 common shares and up to 55,000,000 preferred shares with a nominal value of &amp;#8364;0.12 per share&#13;are authorized to be issued. All shares are registered shares. No share certificates shall be issued.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company`s general meeting&#13;of shareholders approved the right of an independent foundation under Dutch law, or protective foundation, to acquire up to 100%&#13;of the Company`s issued share capital held by others than the protective foundation, minus one share, pursuant to a call option&#13;agreement entered into between us and such foundation, in order to deter acquisition bids. The protective foundation is expected&#13;to enter into a finance arrangement with a bank or, subject to applicable restrictions under Dutch law, the protective foundation&#13;may request us to provide, or cause the Company`s subsidiaries to provide, sufficient funding to the protective foundation to enable&#13;it to satisfy its payment obligation under the call option agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These preferred shares will have&#13;both a liquidation and dividend preference over the Company`s common shares and will accrue cash dividends at a pre-determined&#13;rate. The protective foundation would be expected to re-quire us to cancel its preferred shares once the perceived threat to the&#13;Company and its stake-holders has been removed or sufficiently mitigated or neutralized. We are of the opinion that the call option&#13;does not represent a significant fair value based on a level 3 valuation, due to the fact that the preference shares are restricted&#13;in use and can be cancelled by us as stated above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As of December 31, 2018, the Company&#13;expensed &amp;#8364;83 thousand of ongoing costs to reimburse expenses incurred by the protective foundation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(g) Summary of significant accounting policies&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;This section describes significant&#13;accounting policies adopted in the preparation of these consolidated financial statements. These policies have been consistently&#13;applied to all the years presented, unless otherwise stated. The financial statements are for the Group consisting of InflaRx N.V.&#13;and its subsidiaries.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basis of&#13;preparation&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The consolidated financial statements&#13;of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and interpretations issued&#13;by the IFRS Interpretations Committee (IFRS IC) applicable to companies reporting under IFRS. The financial statements comply with&#13;IFRS as issued by the International Accounting Standards Board (IASB).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The financial statements have&#13;been prepared on a historical cost basis except for share-based payments which are measured at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;These financial statements are&#13;consolidated financial statements for the Group consisting of InflaRx N.V. and its subsidiaries. The financial statements are presented&#13;in euro (&amp;#8364;). Euro is also the functional currency of InflaRx N.V.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All financial information presented&#13;in Euro has been rounded to the nearest thousand. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic&#13;aggregation of the figures that precede them or may deviate from other tables by one thousand euros at a maximum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Subsidiaries are all entities&#13;over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns&#13;from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of&#13;the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Group. They are deconsolidated&#13;from the date control ceases. The acquisition method of accounting is used to account for business combinations by the Group. Intercompany&#13;transactions, balances and unrealized gains on transactions between Group companies are eliminated. Unrealized losses are also&#13;eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries&#13;have been changed where necessary to ensure consistency with the accounting policies adopted by the Group.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The financial statements were&#13;authorized for issue by management on March 26, 2019. All press releases, financial reports and other information&#13;are available on the Investor on the Company`s website: www.inflarx.com&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;New and&#13;amended standards adopted by the Group&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has applied the following&#13;standards and amendments for the first time for their annual reporting period commencing January 1, 2018:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;IFRS 9 Financial Instruments&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;IFRS 15 Revenue from Contracts with Customers&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Amendments to IFRS 2 - Classification and Measurement of Share-based Payments&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Annual Improvements 2014-2016 cycle&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Transfers to Investment Property &amp;#8211; Amendments to IAS 40&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Interpretation 22 Foreign Currency Transactions and Advance Consideration&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has not early adopted&#13;any other standard, interpretation or amendment that has been issued but is not yet effective.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies in the financial&#13;statements, for the first time, IFRS 15 Revenue from Contracts with Customers and IFRS 9 Financial Instruments, which require restatement&#13;of previous financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 15, Revenue from Contracts&#13;with Customers, replaces all current standards and interpretations dealing with revenue recognition and introduces a five-step&#13;model to account for revenue. As the Group is currently not generating revenues, the Group may only be affected by IFRS 15 in the&#13;future when entering into collaboration arrangements or similar transactions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 9 contains a new classification&#13;and measurement approach for financial assets that reflects the business model in which assets are managed and their cash flow&#13;characteristics. IFRS 9 further replaces the &amp;#8216;incurred loss&amp;#8217; model in IAS 39 with a forward-looking &amp;#8216;expected&#13;credit loss&amp;#8217; (ECL) model. This will require considerable judgement about how changes in economic factors affect ECLs, which&#13;will be determined on a probability-weighted basis. IFRS 9 requires new disclosures, in particular about credit risk and expected&#13;credit losses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group applies IFRS 9 with&#13;an initial application date of January 1, 2018. Because the Group held on the initial application date only immaterial non-current&#13;financial assets, cash and cash equivalents, no trade receivables and no derivative financial instruments or financial liabilities,&#13;the impact of IFRS 9 is determined to be nil, except for the disclosures required. Classification for other receivables and cash&#13;and cash equivalents changed from &amp;#8220;loans and receivables&amp;#8221; (IAS 39) to &amp;#8220;amortized cost&amp;#8221; (IFRS 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The impact of IFRS&amp;#160;9 in the&#13;absence of material financial instruments was nil. A restatement of the consolidated statement of financial position as at January&#13;1, 2018 was not necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Most of the other amendments listed&#13;above did not have any impact on the amounts recognized in prior periods and are not expected to significantly affect the current&#13;or future periods.&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;New standards&#13;and interpretations not yet adopted&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Certain new accounting standards&#13;and interpretations have been published that are not mandatory for December 31, 2018 reporting periods and have not been early&#13;adopted by the Group. The Group&amp;#8217;s assessment of the impact of these new standards and interpretations is set out below.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;IFRIC 23 Uncertainty over Tax Treatments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Prepayment Features with Negative Compensation (Amendments to IFRS 9).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Long-term Interests in Associates and Joint Ventures (Amendments to IAS 28).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Plan Amendment, Curtailment or Settlement (Amendments to IAS 19).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Annual Improvements to IFRS Standards 2015&amp;#8211;2017 Cycle &amp;#8211; various standards.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Amendments to References to Conceptual Framework in IFRS Standards.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;IFRS 17 Insurance Contracts.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;IFRS 16 Leases.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;IFRS 16 was issued in January&#13;2016. It will result in almost all leases being recognized on the balance sheet by lessees, as the distinction between operating&#13;and finance leases is removed. Under the new standard, an asset (the right to use the leased item) and a financial liability to&#13;pay rentals are recognized. The only exceptions are short-term and low-value leases.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group has analyzed all of&#13;the Group&amp;#8217;s leasing arrangements over the last year in light of the new lease accounting rules in IFRS 16.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As at the reporting date, the&#13;Group has non-cancellable operating lease commitments of &amp;#8364;575 thousand (see &amp;#8216;3.&amp;#160;Unrecognized items - (a) Operating&#13;lease obligations&amp;#8217;). Of these commitments, approximately &amp;#8364;10 thousand relate to short-term leases and &amp;#8364;6 thousand&#13;to low value leases which will both be recognized on a straight-line basis as expense in profit or loss. For the remaining lease&#13;commitments, the Group expects to recognize right-of-use assets of approximately &amp;#8364;791 thousand on January 1, 2019, lease&#13;liabilities of &amp;#8364;791 thousand (after adjustments for prepayments and accrued lease payments recognized as at December 31,&#13;2018). Overall net assets will stay approximately the same, and net current assets will be &amp;#8364;240 thousand lower due to the&#13;presentation of a portion of the liability as a current liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group expects that net loss&#13;will decrease by approximately &amp;#8364;5 thousand for 2019 as a result of adopting IFRS&amp;#160;16. Operating cash flows will increase&#13;and financing cash flows decrease by approximately &amp;#8364;240 thousand as repayment of the principal portion of the lease liabilities&#13;will be classified as cash flows from financing activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;4.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Current&#13;and non-current distinction&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group presents current and&#13;non-current assets and current and non-current liabilities as separate classifications in its balance sheet. Current assets include&#13;assets that are sold, consumed or realized as part of the normal operating cycle. The operating cycle of an entity is the time&#13;between the acquisition of assets for processing and their realization in the form of cash or cash equivalents. The Groups operating&#13;cycle is assumed to be 12 months. Some current liabilities, such as trade payables and some accruals for employee and other operating&#13;costs, are part of the working capital used in the entity&amp;#8217;s normal operating cycle. Such operating items are classified as&#13;current liabilities even if they are due to be settled more than 12 months after the reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;5.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Foreign&#13;currency transactions&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Transactions in a foreign currency&#13;are initially translated into the respective functional currency using the spot rate prevailing on the dates of the transaction.&#13;Monetary items which are not denominated in the functional currency are subsequently translated using the rate applicable at the&#13;end of the period. The resulting currency gains and losses are recognized directly in profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On consolidation, the assets and&#13;liabilities of foreign operations are translated into euros at the rate of exchange prevailing at the reporting date and their&#13;statements of profit or loss are translated with monthly average exchange rates during the reporting period. The exchange differences&#13;arising on translation for consolidation are recognized in other comprehensive income (OCI). On disposal of a foreign operation,&#13;the component of OCI relating to that particular foreign operation is reclassified to profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;6.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Research&#13;and development&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development expenses&#13;comprise third party services, wages and salaries, cost of materials, intellectual property related expenses, depreciation and&#13;amortization of relevant equipment and intangibles as well as overhead. Research and development expenses mainly consist of cost&#13;for clinical trials and manufacturing of our clinical drug product, additionally cost are incurred by pre-clinical activities as&#13;well as basic research activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Development expenses must be capitalized&#13;if the criteria of IAS 38 are met. In the periods presented, no development expenses were capitalized because management does not&#13;believe all the recognition criteria of IAS 38 had been met. This assessment is due to the general uncertainties in drug development&#13;and the unpredictability of regulatory requirements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As research expenditure and development&#13;expenditure does not meet the recognition criteria they are treated as an expense when incurred. Development costs previously recognized&#13;as an expense are not recognized as an asset in a subsequent period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;7.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Employee&#13;benefits&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;(i) Short-term employee benefits &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Liabilities for wages and salaries&#13;and cash bonuses are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented&#13;as current employee benefit obligations in the balance sheet. A liability is recognized, if the Group has a present legal or constructive&#13;obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated reliably.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;(ii) Share-based payment transactions &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The grant-date fair value of equity-settled&#13;share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity,&#13;over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which&#13;the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is&#13;based on the number of awards that meet the related service and non- market performance conditions at the vesting date. For share-based&#13;payment awards with immediate vesting, the grant-date fair value of the share-based payment is measured to reflect such conditions&#13;and there is no true-up for differences between expected and actual outcomes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;9.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Government&#13;grants&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group received government&#13;grants in 2018 and prior years on certain investments in non-current assets and the Group still receives grant funds on specified&#13;research and development activities. Income from government grants is recognized under &amp;#8216;other income&amp;#8217; in the consolidated&#13;statement of comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income from the government grants&#13;is recognized at fair value where there is a reasonable assurance that the grant will be received and the Group will comply with&#13;all attached terms and conditions. In prior years grants were collected together with investments in non-current assets, the income&#13;was deferred on a straight-line basis over the useful lives of the respective assets. Contributions supporting certain costs of&#13;research and development are recognized as income when respective reimbursable costs also are incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;10.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Lease&#13;arrangements&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group leases various properties,&#13;laboratory and office equipment and cars. Rental contracts are typically made for fixed periods of one to five years but may have&#13;renewal options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The lease is classified at the&#13;inception date as a finance lease or an operating lease. A lease that transfers substantially all the risks and rewards incidental&#13;to ownership to the Group is classified as a finance lease. Typically the Group&amp;#8217;s contracts are falling under the criteria&#13;of operate leases.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;An operating lease is a lease&#13;other than a finance lease. Operating lease payments are recognized as an operating expense in the statement of profit or loss&#13;on a straight-line basis over the lease term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Finance leases are capitalized&#13;at the commencement of the lease at the inception date fair value of the leased property or, if lower, at the present value of&#13;the minimum lease payments. Lease payments are apportioned between finance charges and reduction of the lease liability so as to&#13;achieve a constant rate of interest on the remaining balance of the liability. Finance charges are recognized in finance costs&#13;in the statement of profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A leased asset is depreciated&#13;over the useful life of the asset. However, if there is no reasonable certainty that the Group will obtain ownership by the end&#13;of the lease term, the asset is depreciated over the shorter of the estimated useful life of the asset and the lease term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;11.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Interest&#13;income&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Interest income is derived from&#13;interest-bearing financial assets, including cash equivalents. Interest income from financial assets at fair value through profit&#13;and loss is included in the net fair value gains/(losses) on these assets. Interest income on cash and cash equivalents, financial&#13;assets at amortized cost calculated using the effective interest method is recognized in the statement of profit or loss as part&#13;of finance income.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;12.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible&#13;assets&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Intangible assets mainly comprise&#13;purchased IT software. Intangible assets are initially measured at acquisition cost, including any directly attributable costs&#13;of preparing the asset for its intended use less accumulated amortization. Amortization begins when an asset is available for use&#13;and amortization is calculated using the straight-line method to allocate cost over the estimated useful lives. Software is amortized&#13;over three years. The useful lives of intangible assets are reviewed at each reporting date. The effect of any adjustment to useful&#13;lives is recognized prospectively as a change of accounting estimate. The Group only owns intangible assets with a definite useful&#13;life.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;13.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Laboratory&#13;and office equipment&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Laboratory and office equipment&#13;are stated at historical cost less accumulated depreciation. Historical cost includes expenditure that is directly attributable&#13;to the acquisition of the items.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;All repairs and maintenance are&#13;charged to profit or loss during the financial period in which they are incurred, because they do not constitute a separate asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Depreciation on leasehold improvements&#13;and equipment is calculated using the straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Laboratory equipment: three to 13 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Office equipment: one to five years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The assets&amp;#8217; residual values&#13;and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Gains and losses on disposals&#13;are determined by comparing the proceeds with the carrying amount and are recognized within &amp;#8216;other income and expenses (net)&amp;#8217;&#13;in the consolidated statement of other comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;14.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Financial&#13;assets and liabilities (financial instruments)&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A financial instrument is any&#13;contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group&amp;#8217;s financial liabilities&#13;comprise trade and other payables. The Group initially recognizes non- derivative financial liabilities on the date that they are&#13;originated and measures them at amortized cost using the effective interest rate method. The Group derecognizes a financial liability&#13;when its contractual obligations are discharged, cancelled or expire.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;15.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income&#13;taxes&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Income taxes comprise current&#13;and deferred taxes. Current and deferred taxes are recognized in profit or loss except to the extent that they relate to items&#13;recognized directly in equity or in other comprehensive loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Current tax is the expected tax&#13;payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting&#13;date, and any adjustment to tax payable in respect of previous years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is recognized in&#13;respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the&#13;amounts used for taxation purposes. Deferred tax is not recognized for temporary differences associated with assets and liabilities&#13;if the transaction which led to their initial recognition is a transaction that is not a business combination and that affects&#13;neither accounting nor tax profit or loss.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax is measured at the&#13;tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted&#13;or substantively enacted by the reporting date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Deferred tax assets and liabilities&#13;are presented net if there is a legally enforceable right to offset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A deferred tax asset is recognized&#13;for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable&#13;profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced&#13;to the extent that it is no longer probable that the related tax benefit will be realized. Unrecognized deferred tax assets are&#13;reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be&#13;available against which they can be used.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Due to its stage of development,&#13;the Company does not report deferred tax assets on its consolidated statement of financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;16.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Fair Value&#13;Measurement&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;A number of the Group&amp;#8217;s&#13;accounting policies and disclosures require the measurement of fair values, for both financial and non-financial assets and liabilities.&#13;When measuring the fair value of an asset or a liability, the Group uses observable market data as far as possible. Fair values&#13;are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12px; padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-top: 6pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 1, quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12px; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 2, inputs other than quoted prices included within Level 1 that are observable for the instrument, either directly (as prices) or indirectly (derived from prices).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12px; padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 10pt; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 3, inputs for instruments that are not based on observable market data (unobservable inputs).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;If the inputs used to measure&#13;the fair value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement&#13;is categorized in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the&#13;entire measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group recognizes transfers&#13;between levels of the fair value hierarchy at the end of the reporting period during which the change has occurred. Further information&#13;about the assumptions made in measuring fair values of share-based payments is included in &amp;#8220;1.&amp;#9;Equity settled share-based&#13;payment arrangements&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The carrying amount of all financial&#13;instruments approximates their fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory>
    <IFRX:DisclosureOfInformationOnHowNumbersWereCalculatedExplanatory contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(a) Material profit or loss items&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Research&#13;and development expenses&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Research and development increased&#13;compared to the prior year due to the Company&amp;#8217;s expanded activities in the area of clinical studies and manufacturing. The&#13;items below drive research and development expenses.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 70%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 9.35pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Research and development expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Third-party services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;3,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;8,856&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;15,909&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;manufacturing&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;&amp;#8212;*&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;5,559&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;4,829&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;clinical, pre-clinical&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;&amp;#8212;*&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;3,297&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;11,080&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Personnel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;1,293&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;4,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;8,037&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;stock-based compensation expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;302&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;3,071&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;5,256&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;643&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;132&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;235&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;661&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;5,278&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;14,415&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;25,028&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;* Detailed cost accounting was&#13;introduced in 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;General&#13;and administrative expenses&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;General and administrative expenses&#13;include the items below. Compared to the prior year the increase is mainly caused by higher personnel expenses, as well as expansion&#13;of the Company&amp;#8217;s business activities and the expense of operating as a public company in the United States.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 70%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Personnel expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;1,134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,948&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;9,147&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.5pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;stock-based compensation expense&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;566&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;1,479&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;i&gt;6,828&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Legal and consulting fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;1,478&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,020&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;316&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;712&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;1,619&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,844&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;5,138&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;12,787&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Employee&#13;benefits&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The following table shows the&#13;items of employee benefits:&amp;#9;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 70%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Employee benefits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Wages and salaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;1,467&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,897&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;4,501&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Social Security contributions*&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;182&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;350&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Stock-based compensation expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;868&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;4,550&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;12,085&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;248&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2,462&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;7,629&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;17,184&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;* Employer's share of social security contributions&amp;#9;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The number of employees rose from&#13;20.0 FTE (full time equivalents) at the end of 2017 to 36.8 FTE at the end of 2018 (numbers as of balance sheet date, not an average&#13;number).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;4.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net Financial&#13;Result&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The net financial result is comprised&#13;of the following items:&amp;#9;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Foreign exchange income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;8,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,183&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;1&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;-&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;130&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;10,433&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Finance costs&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Foreign exchange expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;2,046&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;2,565&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;107&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2,049&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;4,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2,731&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Net financial result&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;(2,048)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;(4,793)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;7,702&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 69%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign&#13;exchange income and expense is mainly derived from the translation of the Company&amp;#8217;s U.S. dollar cash, cash equivalents and&#13;marketable securities. These funds are translated at the exchange rates prevailing on the reporting date. Any resulting translation&#13;differences&#13;are recognized in profit and loss. These gains (&amp;#8364; 8,250 thousand in 2018, &amp;#8364;&amp;#160;nil for 2017 and 2016) and losses&#13;(&amp;#8364; 2,624 thousand in 2018, respectively &amp;#8364; 2,358 thousand for 2017 and &amp;#8364;3 thousand for 2016) are caused by the&#13;exchange rates on the reporting dates, and may not ultimately be realized. Any such gains or losses ultimately will be realized&#13;when U.S. dollar funds are used for R&amp;#38;D expenses or other activities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;On&#13;the reporting date, assets and liabilities are translated at the closing rate. Any foreign exchange rate differences derived from these translations are recognized in the consolidated&#13;statement of profit or loss as part of finance income.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Other finance cost in 2017 and&#13;2016 was mainly driven by interest expense for preferred shares (&amp;#8364;2,229 thousand, &amp;#8364;1,836 thousand respectively).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(b) Income tax expense&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;InflaRx N.V. and its German subsidiary&#13;InflaRx GmbH are subject to corporate taxes, a solidarity surcharge and trade taxes. In prior years as well as in 2017 and 2018&#13;the Group did not incur any income tax. Taxes paid were reimbursed after annual tax declaration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;In Germany, the Group has the&#13;following tax carry forwards:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 80%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;InflaRx N.V.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;7,923&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;33,571&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;InflaRx GmbH&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;34,787&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;34,787&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Since January 1, 2018 InflaRx&#13;GmbH has distributed its losses to the parent Company InflaRx N.V. under a profit and loss transfer agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;German tax loss carried forwards&#13;are available indefinitely for offsetting against future taxable profits. Tax losses of InflaRx GmbH are frozen from 2018 onwards&#13;due to the tax Group with InflaRx N.V. Future losses of InflaRx GmbH will be transferred to InflaRx N.V. Losses at the level of&#13;InflaRx N.V. can be offset in future years considering rules extinguishing tax losses and minimum taxation rules.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Group recognizes deferred&#13;tax assets arising from tax loss carried forwards only to the extent that the Group has sufficient taxable temporary differences&#13;or there is convincing evidence that sufficient taxable profit will be available against which the unused tax losses can be utilized.&#13;As of December 31, 2018 and 2017, management&amp;#8217;s judgment is that such convincing evidence is currently not sufficiently available&#13;and a deferred tax asset is therefore not recognized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The table below shows a reconciliation&#13;between current income taxes recognized in profit or loss and the product of loss before tax multiplied by the Company's applicable&#13;tax rate. The applicable tax rate is composed of 15% corporate income tax and 0.8% solidarity surcharge plus 13.4% trade tax (trade&#13;tax is the sum of the Company`s two German locations, 8.2 percentage points must be paid in Jena and 5.2 percentage points in Planegg&#13;respectively; the split between Jena and Planegg is based on salary costs, therefore the tax rate decreased as the Company hired&#13;new personnel in Planegg):&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;InflaRx &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Loss before taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;(8,939)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;(24,238)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;(29,815)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;30.5%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;31.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;29.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Tax benefits at tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,729&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;7,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;8,715&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Tax losses for which no deferred tax asset was recognized&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;(2,729)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;(7,560)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; background-color: #D5EAEA; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;(8,715)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="3" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 67%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(c) Other non-financial assets&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 80%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Current other assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Prepaid expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;504&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;1,047&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;192&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;542&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;696&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,589&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Prepaid expense mainly consists&#13;of accrued insurance expense for D&amp;#38;O and insurance expenses together with the placement of shares in May 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(d) Financial assets and financial liabilities&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Set out below is an overview of&#13;financial assets and liabilities, other than cash and short-term deposits, held by the Group as at December 31, 2018 and December&#13;31, 2017:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 80%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Non-current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;207&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Current financial assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;101,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Trade and other payables&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;(4,469)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;(6,657)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The fair value of current and&#13;non-current financial assets (primarily quoted debt securities with, credit ratings ranging from AA- to AAA) amounted to &amp;#8364;100,723&#13;thousand (level 1). The Group&amp;#8217;s debt instruments at amortized cost comprised solely of quoted securities that are graded&#13;in the top investment category (AA- to AAA) by credit rating agencies such as S&amp;#38;P Global and, therefore, are considered low&#13;credit risk investments. Based on statistical historical probabilities of default, adjusted for forward-looking factors specific&#13;to the debtors and the economic environment, the Group believes that the expected credit losses for these debt instruments are&#13;immaterial. Furthermore, since acquisition of these debt securities, their credit ratings have remained stable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(e) Equity&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Issue of&#13;share capital&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;On May 8, 2018, a public offering&#13;of common shares was completed pursuant to which the Company sold an aggregate of 1,850,000 common shares with a nominal value&#13;of &amp;#8364;0.12 per share, resulting in gross proceeds from the sale of common shares of &amp;#8364;53.0 million. Directly attributable&#13;transaction costs of &amp;#8364;3.8 million were incurred and paid in connection with the sale of these common shares and deducted&#13;from capital reserves.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Shares&#13;Outstanding&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;As of December 31, 2018, following&#13;the public offering in May 2018 and the exercise of stock options in the third and fourth quarters, the issued capital of the Company&#13;is divided into 25,964,379 common shares. Refer to &amp;#8216;Consolidated Statements of Changes in Shareholders&amp;#8217; Equity for&#13;the Years Ended December 31, 2018, 2017 and 2016&amp;#8217;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;(f) Cash and cash equivalents information&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 80%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;December&#13;        31, 2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;(in thousands of &amp;#8364;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Short-term deposits&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Deposits held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;81,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;32,919&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Deposits held in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;38,876&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&amp;#8212;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;120,105&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;32,919&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash at banks&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Money held in euro&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;2,842&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;21,720&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;Money held in U.S. dollars&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;335&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;748&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;3,177&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;22,468&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; line-height: 107%"&gt;&lt;font style="font: 8pt/106% Times New Roman, Times, Serif"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;123,282&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;55,386&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 8.65pt; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</IFRX:DisclosureOfInformationOnHowNumbersWereCalculatedExplanatory>
    <ifrs-full:OtherExpenseByNature contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">5000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">8000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">7000</ifrs-full:OtherExpenseByNature>
    <IFRX:PurchaseOfCurrentNoncurrentFinancialAssets contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">106445000</IFRX:PurchaseOfCurrentNoncurrentFinancialAssets>
    <IFRX:PurchaseOfCurrentNoncurrentFinancialAssets contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">0</IFRX:PurchaseOfCurrentNoncurrentFinancialAssets>
    <IFRX:PurchaseOfCurrentNoncurrentFinancialAssets contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">0</IFRX:PurchaseOfCurrentNoncurrentFinancialAssets>
    <IFRX:SecuritiesAndOtherInvestmentsCurrent contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">100868000</IFRX:SecuritiesAndOtherInvestmentsCurrent>
    <IFRX:SecuritiesAndOtherInvestmentsCurrent contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</IFRX:SecuritiesAndOtherInvestmentsCurrent>
    <IFRX:MarketableSecuritiesTotal contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">100868000</IFRX:MarketableSecuritiesTotal>
    <IFRX:MarketableSecuritiesTotal contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</IFRX:MarketableSecuritiesTotal>
    <IFRX:SummaryOfSharebasedPaymentsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 90%; padding-top: 1pt; padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 9.35pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of stock options:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding at January 1, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;1,869,192&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #D5EAEA"&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Granted in 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;208,073&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Forfeited in 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.5pt solid"&gt;(26,256)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #D5EAEA"&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding at December 31, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#13;        &lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: black 0.5pt solid"&gt;&lt;b&gt;2,051,009&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 0.25in; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;thereof vested&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;626,933&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-left: 0.25in; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;thereof exercised&lt;/i&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&lt;i&gt;-&lt;/i&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</IFRX:SummaryOfSharebasedPaymentsTableTextBlock>
    <ifrs-full:FinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">101400000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">0</ifrs-full:FinancialAssets>
    <ifrs-full:CreditExposure contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">156800000</ifrs-full:CreditExposure>
    <ifrs-full:CreditExposure contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">123300000</ifrs-full:CreditExposure>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2019-03-20" unitRef="Shares" decimals="INF">25964379</dei:EntityCommonStockSharesOutstanding>
    <ifrs-full:GrossProfit contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-37815000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-19553000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-7122000</ifrs-full:GrossProfit>
    <ifrs-full:RevenueAndOperatingIncome contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-37516000</ifrs-full:RevenueAndOperatingIncome>
    <ifrs-full:RevenueAndOperatingIncome contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-19445000</ifrs-full:RevenueAndOperatingIncome>
    <ifrs-full:RevenueAndOperatingIncome contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-6891000</ifrs-full:RevenueAndOperatingIncome>
    <IFRX:NetFinancialResult contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">7702000</IFRX:NetFinancialResult>
    <IFRX:NetFinancialResult contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">-4793000</IFRX:NetFinancialResult>
    <IFRX:NetFinancialResult contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">-2048000</IFRX:NetFinancialResult>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2018-12-31" unitRef="EUR" decimals="-3">1589000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2017-12-31" unitRef="EUR" decimals="-3">696000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2018-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="-3">1047000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2017-12-31_custom_PrepaidExpensesMember" unitRef="EUR" decimals="-3">504000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2018-12-31_ifrs-full_OtherAssetsMember" unitRef="EUR" decimals="-3">542000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AsOf2017-12-31_ifrs-full_OtherAssetsMember" unitRef="EUR" decimals="-3">192000</ifrs-full:OtherCurrentNonfinancialAssets>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">12085000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">4550000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">868000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">4550000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">12085000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2016-01-01to2016-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">868000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">61727000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">86338000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">848000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">258000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">868000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">4550000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">12085000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2016-01-01to2016-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">868000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2017-01-01to2017-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">80940000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">49384000</IFRX:TotalIncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">51000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">2000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="From2018-01-01to2018-12-31_custom_OtherComponentsOfEquityMember" unitRef="EUR" decimals="-3">51000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">452000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">36000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">416000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-67896000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">94165000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2016-01-01to2016-12-31" unitRef="EUR" decimals="-3">25815000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <dei:EntityExTransitionPeriod contextRef="From2018-01-01to2018-12-31">false</dei:EntityExTransitionPeriod>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31" unitRef="EUR" decimals="-3">-53443000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">90904000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">848000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">222000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">90055000</IFRX:IssueOfShareCapital>
    <IFRX:IssueOfShareCapital contextRef="From2018-01-01to2018-12-31_ifrs-full_SharePremiumMember" unitRef="EUR" decimals="-3">52769000</IFRX:IssueOfShareCapital>
    <IFRX:TotalIssueOfShareCapital contextRef="From2017-01-01to2017-12-31" unitRef="EUR" decimals="-3">81789000</IFRX:TotalIssueOfShareCapital>
    <IFRX:TotalIssueOfShareCapital contextRef="From2017-01-01to2017-12-31_ifrs-full_IssuedCapitalMember" unitRef="EUR" decimals="-3">848000</IFRX:TotalIssueOfShareCapital>
    <IFRX:TotalIssueOfShareCapital contextRef="From2017-01-01to2017-12-31_ifrs-full_CapitalReserveMember" unitRef="EUR" decimals="-3">80941000</IFRX:TotalIssueOfShareCapital>
    <dei:AmendmentDescription contextRef="From2018-01-01to2018-12-31">This Amendment No. 1 on Form 20-F/A (the &#8220;Amendment&#8221;) amends the Annual Report on Form 20-F for the year ended December 31, 2018 of InflaRx N.V. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), as originally filed with the U.S. Securities and Exchange Commission on March 28, 2019 (the &#8220;Original Annual Report&#8221;). We are filing this Amendment solely to (i) change the date of the Report of Independent Registered Accounting Firm (the &#8220;Accountants&#8217; Report&#8221;) on page F-2 hereof to March 26, 2018 (from March 28, 2019); (ii) revise the penultimate sentence of Item 1 in Note 4(g) to our audited annual consolidated financial statements, appearing on page F-20, to read as follows: &#8220;The financial statements were authorized for issue by management on March 26, 2019.&#8221;; and (iii) in the Consolidated Statements of Cash Flows on page F-6, amend (x) the line item for &#8220;other non-cash adjustments&#8221; to read &#8220;421&#8221; instead of &#8220;(83)&#8221; and (y) the line item for &#8220;Interest received&#8221; to read &#8220;1,679&#8221; instead of &#8220;504.&#8221;    This Amendment does not reflect events occurring after the filing of the Original Annual Report and does not modify, update or restate the disclosure therein in any way other than to reflect the amendments described above. No other changes have been made in the Original Annual Report. The filing of this Amendment should not be understood to mean that any statements contained herein are true or complete as of any date subsequent to the date of filing of the Original Annual Report.  The exhibits to this Amendment include updated certificates in Exhibits 12.1, 12.2, 13.1 and 13.2, in each case to reflect the date of this Amendment.</dei:AmendmentDescription>
</xbrli:xbrl>